Brainsway Ltd. (BWAY)
Nasdaq: BWAY · Surgical & Medical Instruments & Apparatus · Jerusalem, IL · filing with the SEC since 2011
Who owns Brainsway Ltd.
As filed with the SECHolders of 5% or more
3
Jonathan Shulkin holds 15% of Ordinary Shares, par value NIS 0.04 per share; American Depository Shares, each representing two Ordinary Shares, as its SCHEDULE 13D/A filed Oct 8, 2025 says.
Directors and officers
13
report now, of 13 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Jonathan Shulkin
SCHEDULE 13D/A · filed Oct 8, 2025 · Ordinary Shares, par value NIS 0.04 per share; American Depository Shares, each representing two Ordinary Shares · 19% in Jul 1, 2025
Harel Insurance Investments & Financial Services Ltd.
SCHEDULE 13G/A · filed Jul 29, 2026 · American Depositary Shares, each representing one Ordinary Share, par value NIS 0.04 per share · 6.8% in May 5, 2026
Meitav Investment House Ltd
SCHEDULE 13G/A · filed Jun 3, 2026 · American Depositary Shares, each representing two Ordinary Shares, par value NIS 0.04 per share · 5.24% in Apr 6, 2026
Avner Hagai
SCHEDULE 13G/A · filed Jan 28, 2025 · Ordinary Shares, par value NIS 0.04 per share · reported falling below 5%
Masters Capital Management, LLC
SCHEDULE 13G/A · filed May 13, 2026 · Ordinary Shares, par value NIS 0.04 per share · reported falling below 5%
What BWAY reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 2 countries, from the list filed with the 20-F filed Apr 20, 2026.
Insider tradesForm 4
7sales
0purchases
0sales on a scheduled plan
3people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Moiseyev Gilad | Chief Technology Officer | 1 | $0 | 0 | 0 | $0 |
| Roth Yiftach | Chief Scientist | 4 | $0 | 0 | 0 | $0 |
| Mitrany Rayten Michal Ety | director | 2 | $0 | 0 | 0 | $0 |